A citation-based method for searching scientific literature

Houtan Noushmehr, Daniel J Weisenberger, Kristin Diefes, Heidi S Phillips, Kanan Pujara, Benjamin P Berman, Fei Pan, Christopher E Pelloski, Erik P Sulman, Krishna P Bhat, Roel G W Verhaak, Katherine A Hoadley, D Neil Hayes, Charles M Perou, Heather K Schmidt, Li Ding, Richard K Wilson, David Van Den Berg, Hui Shen, Henrik Bengtsson, Pierre Neuvial, Leslie M Cope, Jonathan Buckley, James G Herman, Stephen B Baylin, Peter W Laird, Kenneth Aldape. Cancer Cell 2010
Times Cited: 1584

List of co-cited articles
811 articles co-cited >1

Times Cited
  Times     Co-cited

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.
Y Y Juo, F M Johnston, D Y Zhang, H H Juo, H Wang, E P Pappou, T Yu, H Easwaran, S Baylin, M van Engeland,[...]. Ann Oncol 2014

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.
Wolfgang Wick, Michael Platten, Christoph Meisner, Jörg Felsberg, Ghazaleh Tabatabai, Matthias Simon, Guido Nikkhah, Kirsten Papsdorf, Joachim P Steinbach, Michael Sabel,[...]. Lancet Oncol 2012

DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
H Binder, E Willscher, H Loeffler-Wirth, L Hopp, D T W Jones, S M Pfister, M Kreuz, D Gramatzki, E Fortenbacher, B Hentschel,[...]. Acta Neuropathol Commun 2019

Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors.
Antje Wick, Oliver Bähr, Martin Schuler, Kristoffer Rohrberg, Sant P Chawla, Filip Janku, David Schiff, Volker Heinemann, Yoshitaka Narita, Heinz-Josef Lenz,[...]. Clin Cancer Res 2021

Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis.
Pan Du, Xiao Zhang, Chiang-Ching Huang, Nadereh Jafari, Warren A Kibbe, Lifang Hou, Simon M Lin. BMC Bioinformatics 2010

CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.
Masanobu Abe, Miki Ohira, Atsushi Kaneda, Yukiko Yagi, Seiichiro Yamamoto, Yoshihiro Kitano, Tsuyoshi Takato, Akira Nakagawara, Toshikazu Ushijima. Cancer Res 2005

SDH mutations establish a hypermethylator phenotype in paraganglioma.
Eric Letouzé, Cosimo Martinelli, Céline Loriot, Nelly Burnichon, Nasséra Abermil, Chris Ottolenghi, Maxime Janin, Mélanie Menara, An Thach Nguyen, Paule Benit,[...]. Cancer Cell 2013

Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
Mengtao Xiao, Hui Yang, Wei Xu, Shenghong Ma, Huaipeng Lin, Honguang Zhu, Lixia Liu, Ying Liu, Chen Yang, Yanhui Xu,[...]. Genes Dev 2012

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
James R Perry, Normand Laperriere, Christopher J O'Callaghan, Alba A Brandes, Johan Menten, Claire Phillips, Michael Fay, Ryo Nishikawa, J Gregory Cairncross, Wilson Roa,[...]. N Engl J Med 2017

IDH1 and IDH2 mutations in gliomas.
Adam L Cohen, Sheri L Holmen, Howard Colman. Curr Neurol Neurosci Rep 2013

On the origin of cancer cells.
O WARBURG. Science 1956

Systematic pan-cancer analysis of tumour purity.
Dvir Aran, Marina Sirota, Atul J Butte. Nat Commun 2015

Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.
Ioannis Kaffes, Frank Szulzewsky, Zhihong Chen, Cameron J Herting, Ben Gabanic, José E Velázquez Vega, Jennifer Shelton, Jeffrey M Switchenko, James L Ross, Leon F McSwain,[...]. Oncoimmunology 2019

Gene expression profiling of gliomas strongly predicts survival.
William A Freije, F Edmundo Castro-Vargas, Zixing Fang, Steve Horvath, Timothy Cloughesy, Linda M Liau, Paul S Mischel, Stanley F Nelson. Cancer Res 2004

Malignant gliomas in adults.
Patrick Y Wen, Santosh Kesari. N Engl J Med 2008

Glioblastoma and other malignant gliomas: a clinical review.
Antonio Omuro, Lisa M DeAngelis. JAMA 2013

Integrative analysis of 111 reference human epigenomes.
Anshul Kundaje, Wouter Meuleman, Jason Ernst, Misha Bilenky, Angela Yen, Alireza Heravi-Moussavi, Pouya Kheradpour, Zhizhuo Zhang, Jianrong Wang, Michael J Ziller,[...]. Nature 2015

Correlation of an epigenetic mitotic clock with cancer risk.
Zhen Yang, Andrew Wong, Diana Kuh, Dirk S Paul, Vardhman K Rakyan, R David Leslie, Shijie C Zheng, Martin Widschwendter, Stephan Beck, Andrew E Teschendorff. Genome Biol 2016

DNA Methylation in Cancer and Aging.
Michael Klutstein, Deborah Nejman, Razi Greenfield, Howard Cedar. Cancer Res 2016

Epigenetic plasticity and the hallmarks of cancer.
William A Flavahan, Elizabeth Gaskell, Bradley E Bernstein. Science 2017

Gene silencing in cancer in association with promoter hypermethylation.
James G Herman, Stephen B Baylin. N Engl J Med 2003

Conserved role of intragenic DNA methylation in regulating alternative promoters.
Alika K Maunakea, Raman P Nagarajan, Mikhail Bilenky, Tracy J Ballinger, Cletus D'Souza, Shaun D Fouse, Brett E Johnson, Chibo Hong, Cydney Nielsen, Yongjun Zhao,[...]. Nature 2010

DNMT3A mutations in acute myeloid leukemia.
Timothy J Ley, Li Ding, Matthew J Walter, Michael D McLellan, Tamara Lamprecht, David E Larson, Cyriac Kandoth, Jacqueline E Payton, Jack Baty, John Welch,[...]. N Engl J Med 2010

Selective inhibition of tumor oncogenes by disruption of super-enhancers.
Jakob Lovén, Heather A Hoke, Charles Y Lin, Ashley Lau, David A Orlando, Christopher R Vakoc, James E Bradner, Tong Ihn Lee, Richard A Young. Cell 2013

The fundamental role of epigenetic events in cancer.
Peter A Jones, Stephen B Baylin. Nat Rev Genet 2002

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Christian Hartmann, Jochen Meyer, Jörg Balss, David Capper, Wolf Mueller, Arne Christians, Jörg Felsberg, Marietta Wolter, Christian Mawrin, Wolfgang Wick,[...]. Acta Neuropathol 2009

D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells.
Lingjun Zhang, Mia D Sorensen, Bjarne W Kristensen, Guido Reifenberger, Thomas M McIntyre, Feng Lin. Clin Cancer Res 2018

Isocitrate dehydrogenase mutations in gliomas.
Matthew S Waitkus, Bill H Diplas, Hai Yan. Neuro Oncol 2016

Oncometabolites: linking altered metabolism with cancer.
Ming Yang, Tomoyoshi Soga, Patrick J Pollard. J Clin Invest 2013

IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
Xiaoran Zhang, Aparana Rao, Paola Sette, Christopher Deibert, Alexander Pomerantz, Wi Jin Kim, Gary Kohanbash, Yigang Chang, Yongseok Park, Johnathan Engh,[...]. Neuro Oncol 2016

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.
Genglin Jin, Zachary J Reitman, Ivan Spasojevic, Ines Batinic-Haberle, Jian Yang, Oleg Schmidt-Kittler, Darell D Bigner, Hai Yan. PLoS One 2011

α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming.
Pu-Ste Liu, Haiping Wang, Xiaoyun Li, Tung Chao, Tony Teav, Stefan Christen, Giusy Di Conza, Wan-Chen Cheng, Chih-Hung Chou, Magdalena Vavakova,[...]. Nat Immunol 2017

Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
Dusten Unruh, Makda Zewde, Adam Buss, Michael R Drumm, Anh N Tran, Denise M Scholtens, Craig Horbinski. Sci Rep 2019

Mutant IDH1 and thrombosis in gliomas.
Dusten Unruh, Steven R Schwarze, Laith Khoury, Cheddhi Thomas, Meijing Wu, Li Chen, Rui Chen, Yinxing Liu, Margaret A Schwartz, Christina Amidei,[...]. Acta Neuropathol 2016

Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
M D Sørensen, R H Dahlrot, H B Boldt, S Hansen, B W Kristensen. Neuropathol Appl Neurobiol 2018

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
Kosuke Aoki, Hideo Nakamura, Hiromichi Suzuki, Keitaro Matsuo, Keisuke Kataoka, Teppei Shimamura, Kazuya Motomura, Fumiharu Ohka, Satoshi Shiina, Takashi Yamamoto,[...]. Neuro Oncol 2018

The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature.
Victor M Lu, Kyle P O'Connor, Ashish H Shah, Daniel G Eichberg, Evan M Luther, Ricardo J Komotar, Michael E Ivan. J Neurooncol 2020

The epigenomics of cancer.
Peter A Jones, Stephen B Baylin. Cell 2007

DNA methylation aging clocks: challenges and recommendations.
Christopher G Bell, Robert Lowe, Peter D Adams, Andrea A Baccarelli, Stephan Beck, Jordana T Bell, Brock C Christensen, Vadim N Gladyshev, Bastiaan T Heijmans, Steve Horvath,[...]. Genome Biol 2019

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations.
Xiao-Yang Liu, Noha Gerges, Andrey Korshunov, Nesrin Sabha, Dong-Anh Khuong-Quang, Adam M Fontebasso, Adam Fleming, Djihad Hadjadj, Jeremy Schwartzentruber, Jacek Majewski,[...]. Acta Neuropathol 2012

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Michael Weller, Martin van den Bent, Jörg C Tonn, Roger Stupp, Matthias Preusser, Elizabeth Cohen-Jonathan-Moyal, Roger Henriksson, Emilie Le Rhun, Carmen Balana, Olivier Chinot,[...]. Lancet Oncol 2017

Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.
Anne Dirkse, Anna Golebiewska, Thomas Buder, Petr V Nazarov, Arnaud Muller, Suresh Poovathingal, Nicolaas H C Brons, Sonia Leite, Nicolas Sauvageot, Dzjemma Sarkisjan,[...]. Nat Commun 2019

missMethyl: an R package for analyzing data from Illumina's HumanMethylation450 platform.
Belinda Phipson, Jovana Maksimovic, Alicia Oshlack. Bioinformatics 2016

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.